Solve Therapeutics Clinical Trial Pipeline: 3 Active Trials, 5 Changes This Month

3

Active Trials

3

Recruiting

5

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-07-25	NCT06771219 SLV-154 Treatment of Advanced Cancers	Primary endpoint(s) modified
2026-07-25	NCT06771219 SLV-154 Treatment of Advanced Cancers	Enrollment increased: 70 -> 250 participants
2026-07-25	NCT06771219 SLV-154 Treatment of Advanced Cancers	Trial arms changed: 8 -> 6
2026-07-25	NCT06771219 SLV-154 Treatment of Advanced Cancers	date change Primary completion pushed: 2027-01 -> 2027-08
2026-07-25	NCT06771219 SLV-154 Treatment of Advanced Cancers	date change Completion pushed: 2027-04 -> 2027-11

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-07-27	NCT07728942 SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors	Phase 1	Recruiting

Active Trials by Phase

Phase 1

3

Active Trials

NCT ID	Title	Condition	Status
Phase 1
NCT07108114	SLV-324 Treatment of Metastatic Solid Tumors	Metastatic Solid Tumors	Recruiting
NCT06771219	SLV-154 Treatment of Advanced Cancers	Advanced Cancer	Recruiting
NCT07728942	SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors	Metastatic Solid Tumors	Recruiting

Get alerts when Solve Therapeutics's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.